NHS England South East - Provision of Specialised Maternity Care for Patients Diagnosed with Placenta Accreta Spectrum (PAS)

Descriptions

This notice is placed as a Prior Information Notice (PIN) to inform the market that NHS England (NHSE) South East (the Commissioner) intends to commission specialist maternity care services for patients diagnosed with Placenta Accreta Spectrum (PAS). Please note: this has previously been referred to as Abnormally Invasive Placenta (AIP) and is referenced as AIP within the national specification, but will be referenced as PAS throughout any further published documentation. The Commissioner would like to understand the level of provider interest in delivering these services, to help identify any existing or potential capacity and to inform the procurement strategy and contracting options. Consideration is being given to procuring a number of separate contracts, subject to the outcome of market and stakeholder engagement. This may result in a multi-lotted procurement process. NHS England commissions specialist maternity care services for women suspected of, and diagnosed with, PAS from PAS Centres. These services include specialist prenatal diagnosis and risk assessment and definitive treatment of PAS by a multidisciplinary team (MDT) with expertise in complex pelvic surgery. PAS Centres provide specialised treatment as part of a regional network arrangement with local maternity services, in accordance with predefined referral guidelines and protocols. PAS Centres have: • Antenatal imaging (foetal medicine or radiology) • Adult intensive care • Level three neonatal intensive care services • Immediate access to blood products. The aims of the service are to: • Accurately diagnose PAS and determine the clinical risk it poses • Maximise safety for the mother by providing high quality specialised multidisciplinary care for the delivery of women at high risk of PAS. This will be achieved by delivering an evidence-based service that: • Prevents avoidable deaths in a population at very high risk of mortality • Minimises ITU admission and length of stay in ITU • Reduces blood product administration • Reduces the risk of severe maternal morbidity such as cardiac arrest, fistula formation and lower urinary tract trauma • Reduces risk of unnecessary surgical procedures including vertical abdominal incision and hysterectomy • Reduces the risk of iatrogenic injury to women from false positive diagnoses • Improves safety for the baby by minimising iatrogenic premature delivery • Ensures that the quality of the care provided is nationally monitored and subject to a process of continued improvement • Participate in national data collection to improve understanding If you are interested in this opportunity, please register on the e-procurement system, Atamis (details at the end of this notice), by 24th May 2023. A copy of the national service specification can also be found on the Atamis portal. This exercise is being managed by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner(s).